Stocks
VolitionRx LimitedVNRX
AMEXHealthcareBiotechnology$0.18
Price as of · delayed, not real-time
A molecular diagnostics company developing blood-based tests for early cancer detection, with a focus on colorectal cancer screening. Its proprietary Nu.Q platform measures nucleosome modifications to identify cancer-related signals. Investors track VNRX for its potential to disrupt the liquid biopsy market and its ongoing clinical validation studies.
52W Range: $0.16-$9.60
Congressional Interest in VolitionRx Limited (VNRX)
No congressional trades have been disclosed for VolitionRx Limited (VNRX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading VNRX?
No congressional trades found for this stock.